Product Information
FENOFIBRATE 160 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1008 per EA under NDC 68180023209. Its NADAC has been published 263 times since Nov 11, 2020.
The High Outlier badge above means this manufacturer's average price in the Fenofibrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
160 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180023209
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
11/19/2025
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA204019On Market Since
7/1/2020
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 160 MG TABLET has been published 263 times since Nov 11, 2020, and over the history we have for it it has declined 56.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1008 per EA |
|---|---|
| All-time high | $0.2802 (May 12, 2021) |
| All-time low | $0.0950 (May 22, 2024) |
| 52-week high | $0.1339 |
| 52-week low | $0.1008 |
| Median price | $0.1519 |
| Average price | $0.1621 |
| Largest weekly change | +41.1% (Jan 17, 2024) |
| Weeks tracked | 263 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 160 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 160 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1008 per EA (NDC 68180023209), effective Nov 19, 2025.
How has the price of FENOFIBRATE 160 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 160 MG TABLET has declined 56.3%. It has been tracked across 263 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 160 MG TABLET?
Since Nov 11, 2020, the NADAC for FENOFIBRATE 160 MG TABLET has ranged from a low of $0.0950 (May 22, 2024) to a high of $0.2802 (May 12, 2021), with a median of $0.1519 per EA.
Are there cheaper alternatives to FENOFIBRATE 160 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as FENOFIBRATE 160 MG TABLET, but none are currently priced below it.
Who manufactures FENOFIBRATE 160 MG TABLET?
FENOFIBRATE 160 MG TABLET (NDC 68180023209) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification